Gerald George
Family Medicine · Grand Prairie, TXNPI 1356316772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,707 and has fallen 56.3% since, to $746 in 2022.
Across 328 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$612
- Novo Nordisk$598
- AbbVie$501
- Boehringer Ingelheim$403
- Lilly USA, LLC$326
- Amarin Pharma, Inc.$315
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,060100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $612 |
| Novo Nordisk | 41 | $598 |
| AbbVie(2 entities) | 38 | $501 |
| Boehringer Ingelheim | 25 | $403 |
| Lilly USA, LLC | 28 | $326 |
| Amarin Pharma, Inc. | 15 | $315 |
| Merck | 19 | $285 |
| Amgen(2 entities) | 15 | $283 |
| Pfizer | 10 | $178 |
| Johnson & Johnson | 11 | $145 |
| Aytu Biopharma, Inc. | 10 | $139 |
| Kowa Pharmaceuticals America, Inc. | 9 | $136 |
| GSK | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $130 |
| Biohaven Pharmaceuticals, Inc. | 7 | $114 |
| Upsher-smith Laboratories LLC | 6 | $97 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Arbor Pharmaceuticals, Inc. | 4 | $70 |
| Eisai Inc. | 5 | $69 |
| Genentech USA, Inc. | 5 | $68 |
| Adlon Therapeutics L.p. | 3 | $59 |
| Sanofi Pasteur Inc. | 3 | $49 |
| Novartis | 3 | $38 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Antares Pharma, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Shire North American Group Inc | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Organon | 1 | $5 |
How this compares
$5,066 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Grand Prairie
- Juan GavaldaGrand Prairie$273K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.